![FDA Guidance on Medical Device Reporting: Specific Cases](https://www.regdesk.co/wp-content/uploads/2022/01/Monitors-images_vp1.jpeg)
Jan 4, 2022
FDA
The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products, has published a guidance document dedicated to medical device reporting. The document is intended to provide additional clarifications and...
Read More
![FDA Guidance on GUDID Account: Key Concepts](https://www.regdesk.co/wp-content/uploads/2021/11/fda7.png)
Nov 17, 2021
FDA
The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products, has published a guidance document dedicated to Unique Device Identifiers. Apart from other aspects, the guidance covers the matters related to...
Read More
![FDA on BCI Devices: Animal Testing](https://www.regdesk.co/wp-content/uploads/2021/10/Advanced-Manufacturing_Art-1-1080x675.png)
Oct 25, 2021
FDA
The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of medical devices, has published a guidance document dedicated to the Brain-Computer Interface (BCI) medical devices. The document highlights the most important aspects...
Read More
![FDA Announces Medical Device Reporting Changes](https://www.regdesk.co/wp-content/uploads/2019/06/fdaupdates.png)
Jun 25, 2019
North America
The US medical device regulating authority, the FDA, terminated the Alternative Summary Reporting Program, used for reporting for over 10 years. Medical device manufacturers exempted from reporting were informed that they would also be required to submit reports....
Read More
![FDA Issued a Safety Communication on Cybersecurity Vulnerabilities](https://www.regdesk.co/wp-content/uploads/2016/12/fda-1080x675.jpg)
Mar 28, 2019
North America
The medical device regulating authority in the United States, the FDA, issued special warning on cybersecurity threats related to cardiac implantable devices (ICDs). According to the document placed on the official website, the FDA aims to alert both companies and...
Read More